Is Early COVID-19 in Kidney Transplant Recipients Concerning Enough to Halt Transplantation? A Multicenter

Hari Shankar Meshram1, Vivek B Kute1, Himanshu V Patel1

  • 1Department of Nephrology, Institute of Kidney Diseases and Research Centre, Dr. H. L. Trivedi Institute of Transplantation Sciences, Ahmedabad, Gujarat, India.

Transplantation Proceedings
|September 24, 2021
PubMed

Insights

Early coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTR) showed a 2.6% incidence and favorable outcomes. Waitlisted patients faced a higher burden of COVID-19, indicating transplantation can resume safely.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Transplantation Immunology

Background:

  • Limited data exists on the incidence and outcomes of early coronavirus disease 2019 (COVID-19) in kidney transplantation recipients (KTR).
  • Understanding COVID-19's impact on KTR is crucial for managing transplantation during the pandemic.

Purpose of the Study:

  • To determine the incidence and outcomes of early COVID-19 in KTR within 30 days of transplantation.
  • To compare COVID-19 outcomes in KTR with waitlisted patients.

Main Methods:

  • A retrospective multicenter study involving 12 Indian centers.
  • Analysis of symptomatology, demographics, laboratory findings, and outcomes of COVID-19 in KTR post-transplant.
  • Comparison of outcomes between early COVID-19 KTR, overall KTR, and waitlisted patients.

Main Results:

  • The incidence of early COVID-19 in KTR was 2.6% (22/838 transplants).
  • COVID-19 severity in KTR ranged from asymptomatic (18.2%) to severe (13.6%), with mortality not significantly higher than overall KTR (4.5% vs. 8.5%).
  • Waitlisted patients exhibited significantly higher COVID-19 severity (23.9%) and mortality (15.5%) compared to KTR.

Conclusions:

  • Waitlisted patients have a higher burden of COVID-19 compared to KTR.
  • Early COVID-19 in KTR demonstrates favorable outcomes, suggesting transplantation can continue during the pandemic.
  • This study provides guidance for transplant physicians regarding transplantation decisions in the COVID-19 era.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
85
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
98
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
104
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
88
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
239
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
166